GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Equity-to-Asset

SOMNF (SomnoMed) Equity-to-Asset : 0.63 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SomnoMed's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $30.06 Mil. SomnoMed's Total Assets for the quarter that ended in Dec. 2024 was $47.49 Mil. Therefore, SomnoMed's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.63.

The historical rank and industry rank for SomnoMed's Equity-to-Asset or its related term are showing as below:

SOMNF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.36   Med: 0.57   Max: 0.82
Current: 0.63

During the past 13 years, the highest Equity to Asset Ratio of SomnoMed was 0.82. The lowest was 0.36. And the median was 0.57.

SOMNF's Equity-to-Asset is ranked worse than
50.92% of 872 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs SOMNF: 0.63

SomnoMed Equity-to-Asset Historical Data

The historical data trend for SomnoMed's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Equity-to-Asset Chart

SomnoMed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.57 0.48 0.36 0.65

SomnoMed Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.36 0.47 0.65 0.63

Competitive Comparison of SomnoMed's Equity-to-Asset

For the Medical Devices subindustry, SomnoMed's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SomnoMed's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SomnoMed's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where SomnoMed's Equity-to-Asset falls into.


;
;

SomnoMed Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

SomnoMed's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )=Total Stockholders Equity/Total Assets
=29.896/46.351
=0.64

SomnoMed's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=30.056/47.494
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SomnoMed  (OTCPK:SOMNF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


SomnoMed Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of SomnoMed's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


SomnoMed Business Description

Traded in Other Exchanges
Address
20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed Headlines

From GuruFocus

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire 07-26-2022

Full Year 2019 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire 10-28-2022

Full Year 2024 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 08-29-2024

Full Year 2020 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Somnomed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Full Year 2023 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2021 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Half Year 2022 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024